The genomics personalized health market is experiencing rapid expansion, fueled by the growing emphasis on precision medicine and early disease detection. Valued at US$ 9.1 Bn in 2023, the market is projected to reach US$ 33.0 Bn by 2034, advancing at a remarkable CAGR of 12.2% during the forecast period. This growth reflects the increasing adoption of genomic technologies to deliver tailored...
Russian 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Tiếng Việt